First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response Medical Countermeasures May 22, 2020 …
Large Observational Study Shows No Benefit for Hydroxychloroquine in COVID-19 Patients Medical Countermeasures May 22, 2020 …
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection Medical Countermeasures May 6, 2020 …
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine Medical Countermeasures May 5, 2020 …
Hydroxychloroquine Linked to Increased Risk of Cardiac Arrhythmia Medical Countermeasures May 1, 2020 …
Convalescent Plasma Therapy: Johns Hopkins Releases Guidebook, Penn Medicine and UChicago Start Trials Medical Countermeasures April 20, 2020 …
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients Medical Countermeasures April 20, 2020 …
Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients Medical Countermeasures April 20, 2020 …
New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans Medical Countermeasures April 16, 2020 …
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment Medical Countermeasures March 25, 2020 …
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients Medical Countermeasures March 24, 2020 …
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients Medical Countermeasures March 16, 2020 …
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S. Medical Countermeasures February 25, 2020 …
China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19 Medical Countermeasures February 15, 2020 …
Investigational Drugs Reduce Risk of Death from Ebola Virus Disease Medical Countermeasures December 2, 2019 …
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine Medical Countermeasures November 14, 2019 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
